Jul. 15 at 4:21 PM
Jim Cramer's top 10 things to watch in the stock market Wednesday
$JNJ $XLV
Club name Johnson & Johnson delivered a beat-and-raise this morning, though the stock is down 2%. Tremfya, one of its key growth drugs, topped expectations. There was some weakness on the medical-device side, specifically within cardiology. Not ideal, but I am confident they can fix the problem. Could be a chance to buy once the dust settles on the quarter. https://www.cnbc.com/2026/07/15/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension